Treatment of hypoxemia during one-lung ventilation using intravenous almitrine

Department of Anesthesiology, Hôpital Foch, Université Paris-Ouest, Suresnes, France.
Anesthesia & Analgesia (Impact Factor: 3.42). 04/2004; 98(3):590-4, table of contents. DOI: 10.1213/01.ANE.0000099715.40831.2A
Source: PubMed

ABSTRACT We performed this prospective randomized double-blinded study to assess the ability of almitrine to treat hypoxemia during one-lung ventilation (OLV). Twenty-eight patients were anesthetized with propofol, sufentanil, and atracurium; lung separation was achieved with a double-lumen tube. A transesophageal Doppler probe was inserted to evaluate cardiac index. If SpO(2) was equal to or decreased to <95% during OLV (inspired fraction of oxygen of 0.6), patients were included in the study and received a placebo or almitrine (12 microg x kg(-1) x min(-1) for 10 min followed by 4 microg x kg(-1) x min(-1)) infusion until SpO(2) reached 90% or decreased to <90% (exclusion from the study). Eighteen of the 28 patients were included and received either almitrine (n = 9) or a placebo (n = 9). Treatment was discontinued in 1 patient in the almitrine group and 6 in the placebo group (P < 0.05). Treatment was successful (SpO(2) remaining >or=95% during OLV) in 8 patients in the almitrine group and 1 in the placebo group (P < 0.01). Heart rate, arterial blood pressure, and cardiac index did not change throughout the study, but we could obtain an adequate aortic blood flow signal in only half of the patients. Almitrine could be used to treat hypoxemia during OLV. IMPLICATIONS: IV almitrine improves oxygenation during one-lung ventilation without hemodynamic modification. Such treatment could be used when conventional ventilatory strategy fails to treat hypoxemia or cannot be used.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Almitrine enhances hypoxic pulmonary vasoconstriction (HPV) and can improve hypoxemia related to one-lung ventilation (OLV). Studies using almitrine have been conducted without inhaled anesthetics because they could inhibit HPV, counteracting the effect of almitrine. This hypothesis, however, has not been confirmed. This study's aim was to evaluate whether almitrine could improve oxygenation when administered during OLV with sevoflurane anesthesia. A prospective, randomized, double-blind, placebo-controlled trial. A tertiary care, university teaching hospital. Thirty adult patients undergoing open-chest thoracic surgery. Patients were assigned randomly to receive almitrine or placebo during OLV. Respiratory and hemodynamic variables were recorded continuously. Anesthesia was maintained with sevoflurane and remifentanil. Intraoperative techniques and medical teams were the same all over the study. Respiratory and hemodynamic variables were measured during two-lung ventilation and during open-chest OLV. Two-way repeated-measures analysis of variance was used to compare the effects of almitrine and placebo. During OLV, PaO2and shunt fraction worsened in all patients without significant differences between groups. At 30-minutes of OLV, PaO2was 184±67mmHg in the almitrine group and 145±56mmHg in the placebo group, while shunt fraction were 31%±6% and 36%±13%, respectively. Mean pulmonary artery pressure was higher in the almitrine group (31±5v24±5 mmHg,p<0.001). During anesthesia with sevoflurane for open-chest OLV, almitrine failed to improve oxygenation and increased pulmonary artery pressure. The combination of sevoflurane and almitrine should, therefore, be avoided.
    Journal of cardiothoracic and vascular anesthesia 09/2013; 28(4). DOI:10.1053/j.jvca.2013.03.019 · 1.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To improve surgical visualization and facilitate the procedure, one-lung ventilation (OLV) is frequently used during thoracic surgery. Although generally well tolerated, the ventilation-perfusion inequality induced by OLV may lead to a decrease in oxygenation and, at times, hypoxemia. Effective treatment algorithms and strategies are necessary for the treatment of hypoxemia during OLV to ensure that the technique can be continued without interruption and allow for completion of the surgical procedure. Treatment strategies may include applying positive end expiratory pressure to the nonoperative lung, continuous positive airway pressure or low flow oxygen insufflation to the operative lung, decreasing anesthetic agents that interfere with hypoxic pulmonary vasoconstriction (HPV), or switching to total intravenous anesthesia. Although less commonly employed, α-adrenergic agonists may also improve oxygenation during OLV by augmenting HPV. We present a 12-year-old girl who developed hypoxemia during OLV, which was not corrected by the usual maneuvers. Hypoxemia was successfully treated with a phenylephrine infusion. The potential applications of α-adrenergic agonists such as phenylephrine in the treatment of hypoxemia during OLV are discussed and its physiologic basis reviewed.
    12/2013; 2(1):16-8. DOI:10.1055/s-0033-1343734
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung Die zunehmend differenzierten und aufwendigen Operationsverfahren für intrathorakale chirurgische Eingriffe erfordern die sichere Seitentrennung der Atemwege und die Möglichkeit der Ein-Lungen-Ventilation. Da jeder Anästhesist im Rahmen der Versorgung von Traumapatienten oder bei akuten pulmonalen Notfällen mit der Notwendigkeit einer Seitentrennung der Atemwege konfrontiert werden kann, werden in dieser Übersichtsarbeit die derzeit gängigen Verfahren zur Lungentrennung und ihre Anwendung vorgestellt. Auf die besonderen Aspekte der Atemwegssicherung bei schwierigen Atemwegen und der Notwendigkeit der Seitentrennung der Atemwege wird eingegangen. Die resultierenden pathophysiologischen Effekte einer Ein-Lungen-Ventilation werden diskutiert und Strategien zur Aufrechterhaltung einer adäquaten Oxygenierung und Vermeidung einer Hypoxie aufgezeigt.
    Der Anaesthesist 06/2005; 54(6):601-624. DOI:10.1007/s00101-005-0866-6 · 0.74 Impact Factor


1 Download